p21(Waf1/Cip1) acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line

International Journal of Cancer

Volumn 83, Issue 6, 1999, Pages 790-797

  Zhang, Yongke ^a   Fujita, Naoya ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; COMPLEMENTARY DNA; PROTEIN BCL 2; PROTEIN P21; ANTISENSE OLIGODEOXYNUCLEOTIDE; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CDKN1A PROTEIN, HUMAN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; LUNG CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; KINETICS; LUNG TUMOR; METABOLISM; PHYSIOLOGY; PROTO ONCOGENE;

APOPTOSIS; CAMPTOTHECIN; CASPASE 3; CASPASES; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG RESISTANCE, MULTIPLE; ENZYME INHIBITORS; GENES, BCL-2; HUMANS; KINETICS; LUNG NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032585893     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991210)83:6<790::AID-IJC15>3.0.CO;2-6     Document Type: Article

References (18)

1. FUJITA, N. and TSURUO, T., Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem. biophys. Res. Commun., 246, 484-488 (1998).
2. GASCOYNE, R.D., ADOMAT, S.A., KRAJEWSKI, S., KRAJEWSKA, M., HORSMAN, D.E., TOLCHER, A.W., O'REILLY, S.E., HOSKINS, P., COLDMAN, A.J., REED, J.C. and CONNORS, J.M., Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood, 90, 244-251 (1997).
3. GIL-GÓMEZ, G., BERNS, A. and BRADY, H.J.M., A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J., 17, 7209-7218 (1998).
4. Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells. Oncogene, 14, 929-935 (1997).
5. HANNUN, Y.A., Apoptosis and the dilemma of cancer chemotherapy. Blood, 89, 1845-1853 (1997).
6. KLUCK, R.M., BOSSY-WETZEL, E., GREEN, D.R. and NEWMEYER, D.D., The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-1136 (1997).
7. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell. 1, 553-563 (1998).
8. MIYASHITA, T. and REED, J.C., Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81, 151-157 (1993).
9. 2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells. J. biol. Chem., 263, 11887-11891 (1988).
10. WAF1 is required for survival of differentiating neuroblastoma cells. Mol. cell. Biol., 16, 1335-1341 (1996).
11. POLYAK, K., WALDMAN, T., HE, T.C., KINZLER, K.W. and VOGELSTEIN, B., Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10, 1945-1952 (1996).
12. REED, J.C., Double identity for proteins of the Bcl-2 family. Nature (Lond.), 387, 773-776 (1997).
13. SUGIMOTO, Y., TSUKAHARA, S., OH-HARA, T., ISOE, T. and TSURUO, T., Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res., 50, 6925-6930 (1990a).
14. SUGIMOTO, Y., TSUKAHARA, S., OH-HARA, T., LIU, L.F. and TSURUO, T., Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines. Cancer Res., 50, 7962-7965 (1990b).
15. TANG, D.G., LI, L., CHOPRA, D.P. and PORTER, A.T., Extended survivability of prostate-cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res., 58, 3466-3479 (1998).
16. TSURUO, T., Mechanisms of multidrug resistance and implications for therapy. Jap. J. Cancer Res., 79, 285-296 (1988).
17. Wafq/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene, 18, 1131-1138 (1999).
18. ZIEGLER, A., LUEDKE, G.H., FABBRO, D., ALTMANN, K.H., STAHEL, R.A. and ZANGEMEISTER-WITTKE, U., Induction of apoptosis in small-cell-lung-cancer cells by an anti-sense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J. nat. Cancer Inst., 89, 1027-1036 (1997).